Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Metabolomics Market Value Analysis: What Growth Is Expected Over The Forecast Period?
The metabolomics market experienced significant expansion lately, projected to increase from $4.17 billion in 2025 to $4.9 billion in 2026, reflecting a compound annual growth rate of 17.5%. Key drivers behind this historical expansion include heightened research into biomarker discovery, greater utilization of mass spectrometry, intensified focus on cancer metabolism investigations, broader implementation of chromatography systems, and advancements in metabolite profiling methodologies.
The metabolomics industry is poised for substantial expansion in the coming years, projecting a market valuation of $9.29 billion by 2030, driven by a compound annual growth rate of 17.3%. This projected surge is underpinned by several key factors, including advancements in bioinformatics technologies, a growing emphasis on tailored medical treatments, escalating interest in nutrigenomics research, increased exploration of metabolic pathways, and the expanding integration of metabolomics within clinical diagnostic procedures. Furthermore, significant trends anticipated during this forecast period encompass the synergy between precision medicine and metabolomic analysis, the proliferation of cloud-based platforms for metabolomic data management, the application of artificial intelligence for identifying metabolic patterns, the automation of high-volume metabolomics processes, and the utilization of the Internet of Things for continuous metabolic monitoring.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2497&type=smp
Metabolomics Market Growth Drivers: What Factors Are Accelerating Expansion?
The increasing incidence of cancer is anticipated to be a significant catalyst for the expansion of the metabolomics market. Cancer, characterized by the uncontrolled proliferation and potential metastasis of aberrant cells, is becoming more common, particularly among the aging demographic, as age represents the foremost risk factor for the majority of cancer types, with most diagnoses occurring in individuals beyond 65 years of age. Metabolomics plays a crucial role in cancer research by offering a detailed overview of the metabolic alterations within tumor cells, thereby facilitating earlier diagnosis, deeper comprehension of disease progression, and the pinpointing of promising therapeutic avenues. To illustrate, projections from the World Health Organization, a Geneva-based global health authority, indicated in February 2024 that approximately 35 million new cancer cases are forecast for the year 2050, signifying a substantial 77% jump compared to the estimated 20 million cases recorded in 2022. Consequently, the escalating rates of cancer are a direct impetus behind the growth observed in the metabolomics sector.
Metabolomics Market Segmentation Trends And Revenue Drivers
The metabolomics market covered in this report is segmented –
1) By Product And Service: Metabolomics Instruments, Metabolomics Bioinformatics Tools And Services
2) By Indication: Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors Of Metabolism, Other Indications
3) By Application: Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, Other Applications
Subsegments:
1) By Metabolomics Instruments: Chromatography Instruments (Gas Chromatography, Liquid Chromatography), Mass Spectrometry Instruments (LC-MS, GC-MS), NMR Instruments (Nuclear Magnetic Resonance)
2) By Metabolomics Bioinformatics Tools And Services: Software Tools (Data Analysis, Statistical Tools, Modeling Tools), Database Services (Metabolomic Databases), Consulting Services (Data Interpretation, Analytical Support), Training And Support Services
Metabolomics Market Trends: What Is Shaping Future Industry Growth?
Leading entities within the metabolomics sector are prioritizing the development and deployment of Integrated Bioinformatics Platforms, aiming to enhance the analysis of intricate metabolomic datasets and consequently propel progress in areas such as tailored healthcare, the identification of disease indicators, and a deeper comprehension of pathological conditions. An Integrated Bioinformatics Platform constitutes a sophisticated software suite designed to amalgamate diverse bioinformatics utilities and repositories, thereby streamlining the examination and interpretation of biological information. Through the alignment of metabolomics information with Metabolon’s detailed biochemical pathway schematics, scientists gain the ability to elucidate biological functions and the underlying causes of ailments. As an illustration, February 2024 saw the unveiling of Metabolon’s bioinformatics solution by Metabolon, Inc., a firm situated in the United States. The Biomarker Lenses feature within this Integrated Bioinformatics Platform empowers users to employ sophisticated analytical filters, allowing them to concentrate on metabolites associated with particular biological pathways or diseases, thereby fostering a more focused investigation of metabolomic findings. Furthermore, the platform incorporates functionalities for performing statistical assessments, including T-tests and ANOVAs, equipping researchers with the means to construct and evaluate statistical frameworks, manage associated descriptive information, and present outcomes in a visually effective manner.
Metabolomics Market Industry Leaders: Which Organizations Are Driving Competition?
Major companies operating in the metabolomics market are Human Metabolome Technologies Inc., Metabolon Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Agilent Technologies Inc., Thermo Fisher Scientific Inc., Waters Corporation, Biocrates Life Sciences AG, Shimadzu Corporation, Danaher Corporation, PerkinElmer Inc., LECO Corporation, Phenomenome Discoveries Inc., AB Sciex, BG Medicine Inc., Chenomx Inc., Creative Proteomics, Evotec A.G, Merck kgaA, Charles River Laboratories International Inc., Metabowerke GmbH, Metabolomic Diagnostics, Phenomenex Inc.
Access The Complete Metabolomics Market Report:
https://www.thebusinessresearchcompany.com/report/metabolomics-global-market-report
Metabolomics Market Regional Analysis And Leading Geography
North Americawas the largest region in the metabolomics market in 2025. Western Europewas the second largest region in the metabolomics market. The regions covered in the metabolomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
